why choose us

First received: November 01, 2023

Clinical Trial: A Phase ?b Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tumor Infiltrating Lymphocytes

Study Type: INTERVENTIONAL


Official Title: An Open, Single-armed, Phase Ib Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced Melanoma

Brief Summary: 20 participants are expected to be enrolled for the Phase Ib clinical trial?this trail is expected to be finished in 20 months.

Read more